GLOW Stack (GHK-Cu + BPC-157 + TB-500)
Also known as GLOW · aesthetic healing stack
New
Reconstitution & dosing guide
70 mg vial — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only70mg x 10 vials
GLOW(BPC 157 10mg+GHK-CU50mg+TB500 10mg) · Not in current stock
$108 / vial
Prices per vial · Research use only · Not medical advice.
Popular aesthetics-oriented trio combining copper peptide remodeling with dual recovery peptides.
How to picture it
Skin and soft-tissue quality sit at the intersection of matrix remodeling, local repair, and cell migration. GLOW packages GHK-Cu (gene-level remodeling and copper delivery), BPC-157 (local repair and supply routes), and TB-500 (migration and structure) into one research blend. Picture blueprint-and-materials crew, supply-and-protect crew, and structure crew on one site — "from the inside out" recovery and aesthetic-tissue research, not a surface cream story.
Research focus & benefits
- Multi-pathway soft-tissue remodel research
- Skin and recovery blend interest
- Collagen, repair, and migration signaling together
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
GLOW is the VERIX catalog three-peptide vial combining GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg) — 70 mg total — aimed at skin quality, soft-tissue recovery, and from-the-inside-out aesthetics. Evidence is extrapolated from each component rather than from trials of the trio. Closely related KLOW adds KPV as a fourth anti-inflammatory peptide.
Mechanism
Combines copper-peptide matrix remodeling (GHK-Cu) with angiogenic/gut-repair cues (BPC-157) and actin/cell-migration recovery signaling (TB-500). Three independent tissue-repair pathways in one reconstitution.
Research uses
- Component literature for GHK-Cu, BPC-157, and TB-500
- Cosmetic regenerative and post-procedure recovery discussions
- Comparison vs KLOW four-peptide healing blends
Research dosing notes
Often multi-week injectable courses plus topical GHK-Cu. Sterility is non-negotiable for injectables.
Half-life / kinetics
Component-dependent
Common research routes
Reported considerations
- Injection load
- Skin irritation
- Cost and unknown long-term combo safety
Contraindications / cautions
- Copper metabolism disorders
- Active cancer concerns
- Pregnancy
Common research stacks
- Microneedling (cosmetic)
- Sun protection
- Protein intake
Legal / access note
Stack of research/cosmetic ingredients; not an approved drug regimen.